StemGen, Inc.

SGNI · OTC
Analyze with AI
6/30/2021
6/30/2020
6/30/2019
6/30/2018
Operating Activities
Net Income-$433-$231-$426$6
Dep. & Amort.$112$19$60$8
Deferred Tax$0$0-$69$0
Stock-Based Comp.$0$0$69$0
Change in WC$131$152$66$108
Other Non-Cash$48$23$194-$130
Operating Cash Flow-$141-$37-$105-$8
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$23$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$23$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$7$22$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$120$27$66$8
Financing Cash Flow$120$34$88$8
Forex Effect$0$0$0$0
Net Chg. in Cash$1-$3-$17-$1
Supplemental Information
Beg. Cash$0$3$20$1
End Cash$1$0$3$0
Free Cash Flow-$141-$37-$105-$8
StemGen, Inc. (SGNI) Financial Statements & Key Stats | AlphaPilot